Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variety of research, diagnostic, therapeutic development, and precision medicine applications, today...
RAYUS Radiology, a leading national provider of advanced diagnostic and interventional medical imaging services, announces the latest addition to its line of cutting-edge imaging...
Lucid Diagnostics Inc, a commercial-stage cancer prevention diagnostics company and a majority-owned subsidiary of PAVmed In , announced that, the MolDX Program published a Future Effective...
The Eureka Clinical AI platform, from ConcertAI's TeraRecon, now provides clinicians with the state-of-the-art artificial intelligence and deep learning technology necessary to automatically detect and segment...
Theralink Technologies, Inc, a precision oncology company with a novel phosphoprotein and protein assay for breast cancer, announced that it has acquired an exclusive...
